Maria Terizaki

ScholarGPS® ID: 64090849780477

Affiliation
University of Crete, Rethymnon, Greece
Affiliation History

Field
Medicine
Discipline
Rheumatology
Top Specialties
Arthritis | Rheumatoid Arthritis
Metrics Summary
Publication Count
13
Predicted Citations
1
Predicted h-index
1
Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

  • Publications
  • Books
  • Patents
  • NIH/NSF
You must register and claim your profile to add or remove publications from it.
... publications
FILTER BY:
Year
Type
Specialty
Affiliations
Access
Co-Authors
Add
Delete
Comorbidities Burden and Implementation of the Treat–to–Target Strategy in Predicting Real-World Patient Outcomes in Spondyloarthritides (journal article)
Flouri, Irini D. | Repa, Argyro | Avgoustidis, Nestor | Pitsigavdaki, Sofia | Pateromichelaki, Katerina | Marolachaki, Eleni | Terizaki, Maria | Nikoloudaki, Myrto | Eskitzis, Anastasios | Kalogiannaki, Eleni
Mediterranean Journal of Rheumatology, volume 34, issue 4, pages 581- (2023).
10.31138/mjr.310723.cba
Cite | Source
Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study (journal article)
Flouri, Irini | Goutakoli, Panagiota | Repa, Argyro | Bertsias, Antonios | Avgoustidis, Nestor | Eskitzis, Anastasios | Pitsigavdaki, Sofia | Kalogiannaki, Eleni | Terizaki, Maria | Bertsias, George | Sidiropoulos, Prodromos
Rheumatology International, volume 44, issue 2, pages 249-261 (2023).
10.1007/s00296-023-05455-7
Cite | Source
AB0375 IN PATIENTS STARTING ETANERCEPT, MALE SEX, ABSENCE OF COMORBIDITIES AND NO csDMARDs CO-ADMINISTRATION ARE INDEPENDENT PREDICTORS OF LONG-TERM (MORE THAN 3 YEARS) PERSISTENCE TO THERAPY, IRRESPECTIVELY OF THE CLINICAL DIAGNOSIS. (journal article)
Flouri, I. | Repa, A. | Avgustidis, N. | Eskitzis, A. | Molla Ismail Sali, A. | Pitsigavdaki, S. | Pateromichelaki, K. | Bertsias, A. | Kalogiannaki, E. | Terizaki, M. | ... | Sidiropoulos, P.
Annals of the Rheumatic Diseases, volume 81, issue Suppl 1, pages 1314.2-1315 (2022).
10.1136/annrheumdis-2022-eular.4826
Cite | Source
Distinct Long-Term Disease Activity Trajectories Differentiate Early on Treatment with Etanercept in Both Rheumatoid Arthritis and Spondylarthritis Patients (journal article)
Flouri, Irini D. | Repa, Argyro | Bertsias, Antonios | Avgoustidis, Nestor | Eskitzis, Anastasios | Pitsigavdaki, Sofia | Kalogiannaki, Eleni | Terizaki, Maria | Bertsias, George | Sidiropoulos, Prodromos
SSRN Electronic Journal (2022).
10.2139/ssrn.4232783
Cite | Source
OP0299 IN RHEUMATOID ARTHRITIS PATIENTS HIGHER NUMBER OF COMORBIDITIES PREDICTS 6-MONTH INSUFFICIENT RESPONSE TO FIRST BIOLOGIC THERAPY AND EVENTUAL CATEGORIZATION OF THE DISEASE AS DIFFICULT-TO-TREAT (journal article)
Flouri, I. | Repa, A. | Avgustidis, N. | Kougkas, N. | Eskitzis, A. | Molla Ismail Sali, A. | Pitsigavdaki, S. | Pateromichelaki, K. | Kalogiannaki, E. | Terizaki, M. | ... | Sidiropoulos, P.
Annals of the Rheumatic Diseases, volume 80, issue Suppl 1, pages 184.2-184 (2021).
10.1136/annrheumdis-2021-eular.4110
Cite | Source
POS0580 COMORBIDITY BURDEN IS HIGH IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS PATIENTS STARTING BIOLOGICS AND PREDICTS THE INCIDENCE OF SERIOUS ADVERSE EVENTS DURING THERAPY (journal article)
Flouri, I. | Repa, A. | Avgustidis, N. | Kougkas, N. | Eskitzis, A. | Molla Ismail Sali, A. | Pitsigavdaki, S. | Pateromichelaki, K. | Kalogiannaki, E. | Terizaki, M. | ... | Sidiropoulos, P.
Annals of the Rheumatic Diseases, volume 80, issue Suppl 1, pages 523.2-523 (2021).
10.1136/annrheumdis-2021-eular.3956
Cite | Source
FRI0411 COMPARABLE CLINICAL RESPONSES BUT HIGHER TREATMENT ADHERENCE OF SECUKINUMAB COMPARED TO TNF INHIBITORS IN SPONDYLOARTHRITIS PATIENTS: LONG TERM PROSPECTIVE OBSERVATIONAL STUDY IN A TERTIARY HOSPITAL OF GREECE (conference)
Flouri, Irini | Repa, Argyro | Avgustidis, Nestor | Kougkas, Nikolaos | Adamichou, Christina | Eskitzis, Anastasios | Kyfonidou, Paraskevi | Ismail Sali, Ainour Molla | Polia, Styliani | Terizaki, Maria | ... | Sidiropoulos, Prodromos
Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019 (2019)
10.1136/annrheumdis-2019-eular.7877
Cited by (1) | Cite | Source
AB0680 NAIFOLD VIDEOCAPILLAROSCOPY PATTERN CORRELATES WITH ORGAN INVOLVEMENT AND DISEASE OUTCOME IN SYSTEMIC SCLEROSIS: A SINGLE-CENTER OBSERVATIONAL STUDY (conference)
Repa, Argyro | Bertsias, George | Kougkas, Nikolaos | Avgustidis, Nestor | Terizaki, Maria | Kyfonidou, Paraskevi | Sidiropoulos, Prodromos
Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019 (2019)
10.1136/annrheumdis-2019-eular.2273
Cite | Source
PS7:143 Severity assessment of lupus patients: data from the lupus registry in crete, greece (conference)
Gergianaki, I | Fanouriakis, A | Repa, A | Adamichou, C | Terizaki, M | Spyrou, G | Sidiropoulos, P | Boumpas, D | Bertsias, G
11th European Lupus Meeting, Düsseldorf, Germany, 21–24 March 2018, Abstract presentations (2018)
10.1136/lupus-2018-abstract.186
Cite | Source
FRI0236 After discontinuation of the 1st tumor necrosis factor inhibitor (TNFI), non-tnfi biologic agents have similar responses but higher survival compared to a 2nd course of a different tnfi: long-term prospective observational study of patients with r (conference)
Flouri, ID | Repa, A | Avgoustidis, N | Kougas, N | Fanouriakis, A | Papalopoulos, I | Adamichou, C | Kyfonidou, P | Kampouraki, E | Terizaki, M | ... | Sidiropoulos, P
Annual European Congress of Rheumatology, 14–17 June, 2017 (2017)
10.1136/annrheumdis-2017-eular.6817
Cite | Source
SAT0204 Abatacept survival in rheumatoid arthritis patients at 2 years is 59%; its use as a 2nd line biologic agent and lower baseline haq predict better survival in clinical practice: a prospective, observational single center study (conference)
Flouri, ID | Repa, A | Avgoustidis, N | Kougas, N | Fanouriakis, A | Papalopoulos, I | Adamichou, C | Kyfonidou, P | Kampouraki, E | Terizaki, M | ... | Sidiropoulos, P
Annual European Congress of Rheumatology, 14–17 June, 2017 (2017)
10.1136/annrheumdis-2017-eular.6931
Cite | Source
SAT0054 Favorable Long-Term Outcome of Early Inflammatory Arthritis in Clinical Practice: High Baseline Haq and Das28 at 3 Months Predict Use of Biologics (journal article)
Fanouriakis, A. | Papalopoulos, I. | Gergianaki, E. | Spyrou, G. | Rapsomaniki, P. | Terizaki, M. | Avgoustidis, N. | Repa, A. | Boumpas, D.T. | Sidiropoulos, P.
Annals of the Rheumatic Diseases, volume 75, issue Suppl 2, pages 683.1-683 (2016).
10.1136/annrheumdis-2016-eular.5569
Cite | Source
AB0005 Investigation of the Genetic Overlap Between Rheumatoid and Psoriatic Arthritis in a Genetic Homogeneous Population of Greece (journal article)
Myrthianou, E. | Zervou, M.I. | Kougas, N. | Terizaki, M. | Boumpas, D.T. | Kardassis, D. | Sidiropoulos, P. | Goulielmos, G.N.
Annals of the Rheumatic Diseases, volume 74, issue Suppl 2, pages 892.3-892 (2015).
10.1136/annrheumdis-2015-eular.2941
Cite | Source